Literature DB >> 28277307

Pathology of borderline and invasive cancers.

Jaime Prat1.   

Abstract

Epithelial ovarian tumors are heterogeneous neoplasms primarily classified according to cell type. They are further subdivided into benign, borderline, and malignant (carcinomas), and this subdivision is very important as it correlates with behavior. Borderline ovarian tumors show epithelial proliferation higher than that seen in their benign counterparts and variable nuclear atypia; however, in contrast to carcinomas, there is no destructive stromal invasion, and their prognosis is much better. Ovarian carcinomas are the most common ovarian cancers and the most lethal gynecological malignancies. On the basis of histopathology and molecular genetics, they are divided into five types (high-grade serous (70%), endometrioid (10%), clear cell (10%), mucinous (3%), and low-grade serous carcinomas (<5%)), which are morphologically diverse and account for over 95% of cases. These tumors are essentially distinct diseases, as indicated by differences in epidemiological and genetic risk factors, precursor lesions, patterns of spread, molecular alterations, response to chemotherapy, and prognosis. For a successful specific treatment, reproducible histopathological diagnosis of the tumor cell type is critical.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  borderline tumor; clear cell carcinoma; endometrioid carcinoma; high-grade serous carcinoma; low-grade serous carcinoma; mucinous carcinoma

Mesh:

Year:  2016        PMID: 28277307     DOI: 10.1016/j.bpobgyn.2016.08.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  19 in total

1.  Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors.

Authors:  Taira Hada; Morikazu Miyamoto; Hiroki Ishibashi; Haruka Kawauchi; Hiroaki Soyama; Hiroko Matsuura; Takahiro Sakamoto; Soichiro Kakimoto; Tadashi Aoyama; Hideki Iwahashi; Rie Suzuki; Hitoshi Tsuda; Masashi Takano
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Cytologic features of upper gynecologic tract adenocarcinomas exhibiting mesonephric-like differentiation.

Authors:  Brie Kezlarian; Stephanie Muller; Vitor Werneck Krauss Silva; Carlene Gonzalez; Daniel J Fix; Kay J Park; Rajmohan Murali
Journal:  Cancer Cytopathol       Date:  2019-07-18       Impact factor: 5.284

Review 3.  Gynaecological cancers and leptin: A focus on the endometrium and ovary.

Authors:  A Ray; J Fornsaglio; S Dogan; S Hedau; D Naik; A De
Journal:  Facts Views Vis Obgyn       Date:  2018-03

4.  Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors.

Authors:  Ziyang Lu; Bin Li; Chao Gu
Journal:  J Int Med Res       Date:  2019-08-21       Impact factor: 1.671

5.  Role of Retinoblastoma Protein Family (Rb/p105 and Rb2/p130) Expression in the Histopathological Classification of Borderline Ovarian Tumors.

Authors:  Valeria Masciullo; Paola Valdivieso; Giulia Amadio; Angela Santoro; Giuseppe Angelico; Alessandro Sgambato; Silvia Boffo; Antonio Giordano; Giovanni Scambia; Gian Franco Zannoni
Journal:  Front Med (Lausanne)       Date:  2020-11-11

Review 6.  New Predictive Biomarkers for Ovarian Cancer.

Authors:  Ghofraan Abdulsalam Atallah; Nor Haslinda Abd Aziz; Chew Kah Teik; Mohamad Nasir Shafiee; Nirmala Chandralega Kampan
Journal:  Diagnostics (Basel)       Date:  2021-03-07

Review 7.  Serous borderline ovarian tumours: an extensive review on MR imaging features.

Authors:  Hilal Sahin; Asli Irmak Akdogan; Janette Smith; Jeries Paolo Zawaideh; Helen Addley
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.629

8.  Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass.

Authors:  Xin-Ping Yu; Ying Liu; Jin-Wen Jiao; Hong-Juan Yang; Rui-Jing Wang; Shuai Zhang
Journal:  Med Sci Monit       Date:  2020-08-17

Review 9.  The Endometriotic Tumor Microenvironment in Ovarian Cancer.

Authors:  Jillian R Hufgard Wendel; Xiyin Wang; Shannon M Hawkins
Journal:  Cancers (Basel)       Date:  2018-08-07       Impact factor: 6.639

Review 10.  Borderline ovarian tumours: management in the era of fertility-sparing surgery.

Authors:  Mattia Maramai; Fabio Barra; Mario Valenzano Menada; Sara Stigliani; Melita Moioli; Sergio Costantini; Simone Ferrero
Journal:  Ecancermedicalscience       Date:  2020-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.